Polymers in gene therapy technology

Hossein Hosseinkhani, Fatemeh Abedini, Keng Liang Ou, Abraham J. Domb

研究成果: 雜誌貢獻文章同行評審

31 引文 斯高帕斯(Scopus)

摘要

There are several barriers to gene delivery. One of the biggest challenges is the design of appropriate vectors. Currently, nonviral vectors have received significant attention because of low toxicity, potential for tissue specificity, stability during storage, lack of immunogenicity, and relatively low production cost. Despite the high efficiency of viral vectors, they show limited clinical applications because of potentially fatal adverse effects and because of the likelihood of the immune response shutting down the transgene expression system. Nonviral technologies comprise plasmid-based expression systems harboring a gene that encodes a therapeutic protein along with a synthetic gene delivery system. This review provides a broad perspective on recent improvements in the development of four kinds of nonviral vectors that are based on polymers, peptides, lipids, and DNA and discusses the cytotoxicity associated with gene therapy.
原文英語
頁(從 - 到)198-211
頁數14
期刊Polymers for Advanced Technologies
26
發行號2
DOIs
出版狀態已發佈 - 二月 1 2015

ASJC Scopus subject areas

  • Polymers and Plastics

指紋 深入研究「Polymers in gene therapy technology」主題。共同形成了獨特的指紋。

引用此